A new report by WHO has laid bare the worrying extent to which the COVID-19 pandemic has disrupted efforts to combat tuberculosis. At the centre of the 2022 Global Tuberculosis Report are the statistics on case notifications. In 2019, the year before the COVID-19 pandemic was declared, 7·1 million new cases of tuberculosis were reported worldwide. In 2020, this number dropped to 5·8 million, before recovering somewhat to 6·4 million in 2021. WHO is confident that the reduced number of reported cases of tuberculosis does not represent a genuine drop in the disease burden. The most likely explanation is, instead, that the first 2 years of the pandemic saw dramatically reduced access to health care and diagnostic services.

Tuberculosis will be high on the global health agenda in 2018, but tuberculosis in children is often overlooked. Talha Burki reports.

Ethiopia's political commitment, along with an army of thousands of health extension workers, is helping it to successfully tackle tuberculosis. Talha Burki reports from the capital, Addis Ababa.

Bold plans are being set in motion to build on the success of tackling tuberculosis so far, but despite these past successes the need to act is no less urgent. Talha Burki reports.

After 40 years of no new therapies, approval of bedaquiline and delamanid for the treatment of tuberculosis is a cause for optimism. But is that hope well founded?

Adequate funding is crucial in the fight against tuberculosis, but progress worldwide is threatened by underinvestment in tuberculosis research and development.